Issue link: http://deals.uberflip.com/i/1533898
North America's Innova ve Leader in Holis c Healing Products #67482 BUSINESS HIGHLIGHTS Founded over 10 years ago, this Company is focused on holis c healing and was founded with the inten on of using combina ons of herbs to address health problems comprehensively. The Company's products are designed to relieve symptoms, address the underlying issues, and support the body's healing process. These formula ons are developed by a master herbalist and are based on tradi onal herbal knowledge combined with modern medical insights. The Company believes that the future of natural health products lies in providing complete solu ons to common problems. Providing these holis cally engineered complete solu ons empowers the un-trained customers to address their own issues. Each pre-packaged solu on comes with the instruc ons for use that ensure success without requiring them to become an herbal expert . INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 DISCLAIMER: All informa on contained in this document has been provided by the subject company to Genera onal Equity and while believed to be correct has not been verified. Accordingly, Genera onal Equity makes no representa ons or warran es as to the accuracy and truthfulness of such informa on. The recipient hereof acknowledges that Genera onal Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Genera- onal Equity of this document. At all mes Genera onal Equity and/or its affiliate network members are agents for the seller and not for the buyer. Genera onal Equity's fees are paid by the seller. INVESTMENT APPEAL Patents: The company has a great deal of proprietary informa on regarding its novel formula ons and products. Some of the products are generated with proprietary custom equipment. The largest selling product is patent protected for natural and pharmaceu cal embodiments. Outstanding Growth Opportuni es: The Company currently has less than 1% of an enormous global market. Several opportuni es exist for the Company to significantly increase revenue and profit by leveraging the Company's products which address huge global health concerns. These opportuni es are a ainable given the appropriate investments in capital and human resources. Research & Development Expenditure: Government and private policies encourage research and development (R&D) of new medical treatments. The market is moving towards a far greater acceptance of natural health treatments. With the extremely effec ve products and treatment techniques of The Company, it is perfectly posi oned to expand the reach of these therapeu c remedies through the avenue of R&D. Genera onal Equity 11175 Cicero Dr Suite 100 Alphare a, GA 30022 SIGN NDA ► EBITDA MARGINS 2020: 38.5% 2021: 26.2% 2022: 17.0% 2023(P): 20.6% ACTIVE ACCOUNTS 2022: 3000+ Rate of Repeat Business: 50% GEOGRAPHIC MARKETS United States: 90% Foreign: 10% REVENUE / EBITDA $1.5M $309K 2023 REVENUE (PROJ) 2023 EBITDA (PROJ) This Offering is Pre- Qualified for SBA Financing. Click here to learn more Emil Nirkis Vice President, M&A Email: enirkis@genera onal.com Cell: 678-915-9561 REVENUE SOURCES CUSTOMER MARKETS $1.4M $239K 2022 REVENUE 2022 EBITDA